Clinical Case Reports (Nov 2022)

A rare case of SRD5A3‐CDG in a patient with ataxia and telangiectasia: A case report

  • Sayyed Hesamedin Nabavizadeh,
  • Rafat Noeiaghdam,
  • Leila Johari,
  • Seyed Ali Hosseini,
  • Hossein Esmaeilzadeh,
  • Soheila Sadat Alyasin

DOI
https://doi.org/10.1002/ccr3.6564
Journal volume & issue
Vol. 10, no. 11
pp. n/a – n/a

Abstract

Read online

Abstract Steroid 5α‐reductase type 3 congenital disorder of glycosylation (SRD5A3‐CDG) is an extremely rare congenital disease. Common manifestations are developmental delay, intellectual disability, ophthalmological abnormalities, cerebellar abnormalities, ataxia, and hypotonia. Here, we discuss a seven‐year‐old boy with SRD5A3‐CDG (homozygous variant c.57G>A [p.Trp19Ter]), featuring the unprecedented finding of telangiectasia.

Keywords